Merck is first to seek approval of cervical cancer vaccine

12/6/2005 | CNNMoney

Merck has filed for FDA approval of its vaccine Gardasil, taking the lead in the race to market a vaccine against cervical cancer. GlaxoSmithKline plans to apply for European approval of its vaccine candidate Cervarix in the first half of 2006. Merck and Sanofi Pasteur MSD, which would market Gardasil in Europe, plan to file for approval there and in Australia before the end of 2005.

View Full Article in:

CNNMoney

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR